Last Update 05 Aug 26
Fair value Increased 8.87%HSX: Future Returns Will Balance Dividend Appeal With Execution And Rating Risks
The analyst price target for Hiscox has increased to £18.90 from £17.36. This change reflects updated assumptions on fair value, alongside recent target increases from several firms that cite supportive views on growth, margins and P/E valuation.
Analyst Commentary
Recent research on Hiscox shows a mix of optimism on valuation and execution alongside some more measured stances on upside. Price targets now cluster in the range of 1,800 GBp to 2,050 GBp, which indicates where analysts see fair value based on their latest models.
Bullish Takeaways
- Bullish analysts have moved price targets higher, with the top end at 2,050 GBp. This signals confidence that Hiscox can justify a higher valuation through its current business mix and earnings profile.
- Some of the more optimistic research maintains positive ratings alongside higher targets, which suggests comfort with Hiscox execution on underwriting and cost discipline that underpin their fair value work.
- The step up in targets from 1,700 GBp to 1,800 GBp and then up to 2,050 GBp points to a view that Hiscox has levers for profit growth that are not yet fully reflected in previous target ranges.
- Bullish analysts appear comfortable with current P/E assumptions, indicating that they see the valuation as supported by the company’s earnings outlook and risk profile.
Bearish Takeaways
- The move from a Buy to an Add rating, even with a 1,960 GBp target, shows some analysts are more cautious on upside from here and see Hiscox as closer to their view of fair value.
- This more reserved stance suggests concern that much of the easy valuation re rating may already be reflected in the share price, which may limit potential for further multiple expansion without stronger evidence on earnings.
- Bearish analysts appear more sensitive to execution risks such as underwriting consistency and cost control, which could affect how comfortably Hiscox meets the assumptions embedded in current targets.
- The range of ratings from positive to more neutral highlights that not all analysts are aligned on risk reward at current levels. This is relevant if you are weighing how much confidence to place on the higher end of the target spectrum.
What’s in the News for Hiscox
- Hiscox is reportedly reviewing its European operations and considering a sale of parts of the business, according to M&A rumors dated 8 July 2026. Source: Key Developments.
- The potential divestment under review could reshape Hiscox exposure to European specialty commercial and retail insurance, with possible implications for how capital is allocated across regions. Source: Key Developments.
- Reports indicate that any sale of selected European units may free up capital that could be redirected to higher priority business lines or returned to shareholders, subject to regulatory and board approvals. Source: Key Developments.
- Hiscox recommended a final dividend of 35.9¢ per share, equivalent to 26.74p per share, for shareholders on the register as of 24 April 2026, with payment in Sterling unless a US dollar election is made. The dividend was approved at the AGM on 14 May 2026. Source: Key Developments.
Valuation Changes for Hiscox
- Fair Value has risen from £17.36 to £18.90, which is a move of about 9% higher in the latest model update for Hiscox.
- The Discount Rate is unchanged at 6.94%, so the updated valuation for Hiscox does not rely on a different required return assumption.
- Revenue Growth in the model has edged up from 13.47% to 13.62%, a small increase that fine tunes the dollar revenue outlook rather than resetting it.
- The Profit Margin has been adjusted slightly from 12.22% to 12.26%, which represents a modest uplift in expected dollar earnings efficiency.
- The Future P/E has moved from 11.26x to 12.41x, which indicates that a higher valuation multiple is being applied to Hiscox in the refreshed assumptions.
Key Takeaways
- High capital returns constrain future expansion and operational investment, potentially affecting net margins and earnings.
- New Bermuda tax increases and anticipated catastrophe losses may compress net margins and profitability.
- Hiscox's strategic emphasis on technology investments, strong underwriting, and shareholder value initiatives could drive operational efficiency and bolster market competitiveness.
Catalysts
About Hiscox- Through its subsidiaries, provides insurance and reinsurance services in the United Kingdom, Europe, the United States, and internationally.
- Hiscox's future growth may be constrained by current high levels of capital returns to shareholders via increased dividends and a substantial share buyback, which could limit the capital available for future expansion and operational investments, potentially affecting net margins and earnings.
- Although Hiscox anticipates growth in the London market segment, there are concerns that rate changes could reduce growth opportunities, impacting revenue potential if market conditions do not favor additional capital deployment.
- The introduction of a new Bermuda corporate income tax, which is anticipated to increase the group’s effective tax rate to between 15% and 20%, may reduce net margins and profitability going forward.
- The expectation for future catastrophe losses, such as the California wildfires' significant impact on reinsurance operations, may heighten risk exposure, lead to higher reinsurance costs, and compress net margins.
- Increased investments in technology and marketing, though necessary for growth, raise short-term operating expenses (e.g., a 25% increase in brand investment) and could pressure net margins if revenue growth does not keep pace with these expenditures.
Hiscox Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Hiscox's revenue will grow by 13.6% annually over the next 3 years.
- Analysts assume that profit margins will shrink from 15.0% today to 12.3% in 3 years time.
- Analysts expect earnings to reach $723.9 million (and earnings per share of $2.44) by about August 2029, up from $604.1 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting $826.0 million in earnings, and the most bearish expecting $633.2 million.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 12.4x on those 2029 earnings, down from 12.6x today. This future PE is greater than the current PE for the GB Insurance industry at 12.1x.
- Analysts expect the number of shares outstanding to decline by 3.69% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 6.94%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Hiscox has demonstrated strong financial performance with record profits of $685 million and a return on equity of 19.8%, which could indicate continued earnings growth and stability.
- The company is experiencing a significant growth in its retail segment, with a particular focus on the U.K. and European markets, which may positively impact revenues.
- Hiscox is focused on disciplined cycle management and achieving a combined ratio of 81.6% in a year with active losses, showcasing strong underwriting practices that could maintain or improve net margins.
- The company is heavily investing in technology and AI to improve underwriting efficiency and distribution, likely leading to enhanced operational efficiency and potential revenue growth.
- With the ongoing share buyback and increased dividends, Hiscox is bolstering shareholder value, which may help sustain a strong share price despite potential challenges.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of £18.9 for Hiscox based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of £21.24, and the most bearish reporting a price target of just £11.43.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $5.9 billion, earnings will come to $723.9 million, and it would be trading on a PE ratio of 12.4x, assuming you use a discount rate of 6.9%.
- Given the current share price of £17.77, the analyst price target of £18.9 is 6.0% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Hiscox?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.